Relizen

by Bonafide · tablet or pill · 60 tablets

  • On the market (NIH)
  • DSLD label 203510
  • Serving 2 tablets
  • 30 servings

Relizen by Bonafide lists one ingredient: pollen extract GC-FEM, without an amount per serving of 2 tablets. Its current label entered the NIH Dietary Supplement Label Database on June 24, 2019.

What is in Relizen?

Each row as the label prints it, per serving of 2 tablets. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

Relizen: Supplement Facts rows against the market (DSLD label 203510, January 2026 release)
IngredientAmount% DVAmong products listing it
Purified Cytoplasmic Blend320 mg
Pollen + Pistol extract PI-82in the blend, no amount given
Pollen extract GC-FEMin the blend, no amount given

Source: NIH ODS Dietary Supplement Label Database, label 203510 (entered June 24, 2019), version 9.4.0. See the label on DSLD. Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

Every amount on this label with a position sits within the middle 80% of the products that list the same ingredient; 1 ingredient sits inside a blend, so their amounts cannot be compared.

The NIH database records one serving a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

2 products list the very same ingredients; the nearest amounts come first.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
Relizen takes time to work. You should begin to feel relief around month two or three and survey data shows that relief improves with prolonged use.
Suggested use: Take two tablets once per day or as directed. Continue for prolonged benefit.
Warnings
For questions, comments, or to report a serious adverse event please visit www.HelloBonafide.com or call 1-833-266-2343
Allergens and what it does not contain
Relizen is clinically shown to reduce the severity and frequency of menopausal hot flashes and night sweats and provides you the relief you've been waiting for - without hormones, harsh chemicals or soy.
Discover hormone-free relief from hot flashes and night sweats - keeping you cool and dry.
Hormone-free and safe

Source: label statements in DSLD label 203510.

What else is on the label?

Other ingredients: Isomalt, Maltodextrin, Microcrystalline Cellulose, Acacia, Magnesium Stearate, D-Alpha-Tocopheryl, Hydroxypropyl Methylcellulose, Silica, Polysorbate.

How many labels does Relizen have?

One label is on file, entered on June 24, 2019.

  1. Label 203510 (current) Entered June 24, 2019 · on the market · 60 tablets

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names Bonafide Health LLC (distributor), Purchase, NY. All Bonafide products.

Where next?